BioSpace News Archive

Medtronic plc (NYSE:MDT), a global leader in structural heart therapies, today announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of the Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) system in patients with severe, symptomatic tricuspid regurgitation,

Vivera Pharmaceuticals, Inc. is pleased to announce the launch of an exclusive partnership with OmeCare, a leading CLIA-certified global clinical laboratory provider.

Bioclinica’s IRT reduces the average setup time 50 to 75 percent for each new study compared to IRT systems built from the ground up

LightForce Orthodontics, makers of the world’s first and only fully customizable 3D-printed bracket system, announced it raised a $14 million Series B round led by Tyche Partners with follow-on investment from Matrix Partners and AM Ventures.

An investigator-initiated study (IIS) supported by Octapharma USA has reported that intravenous immunoglobulin (IVIg) significantly improved hypoxia and reduced hospital length of stay and progression to mechanical ventilation in patients with COVID-19 pneumonia

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that an independent analyst report by Ari Zoldan was published on Seeking Alpha, a crowd-sourced content service for financial markets.

Stand Up for APA, a nonprofit working to ensure that all women in the United States receive access to the most accurate non-invasive prenatal testing (NIPT) options, today applauded the American College of Obstetricians and Gynecologists’ (ACOG) new set of guidelines that support NIPT use for all pregnant women, regardless of age or baseline risk.

Only half of the adults in the United States get the exercise they need to help reduce and prevent chronic diseases.

Virtual two-day event to feature guest appearance by Dr. Anthony Fauci and sessions open to public for the first time ever.

Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the Cantor Virtual Global Healthcare Conference.